NASHVILLE, Tenn., Jan. 07, 2026 (GLOBE NEWSWIRE) — Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today announced members of its management team will participate in the following investor conferences this winter, which will include hosting meetings around the annual J.P. Morgan Healthcare Conference. LifeSci Advisors 15th Annual Corporate Access Event Date: Monday, January 12thLocation: The Beacon Grand, San Francisco, Calif.Format: One-on-one meetings with management Additional “JPM Week” Investor MeetingsDate: Monday, January 12th through Wednesday, January 14thLocation: San Francisco, Calif.Format: One-on-one meetings with management BTIG 13th Annual Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools ConferenceDate: February 9th – 11th Location: Cliff Lodge, Snowbird, UtahFormat: One-on-one meetings and skiing with managementTo request an in-person meeting with management on Monday, January 12th, during the week of the 44th Annual J.P. Morgan Healthcare Conference, either register at LifeSci Partners Corporate Access Event 2026 or contact our LifeSci Partners representatives Alexandra Grossman (alex@lifesciadvisors.com). For meetings at the BTIG conference, please contact your sales representative at BTIG. About Insight Molecular Diagnostics, Inc. Insight Molecular Diagnostics is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit https://investors.Insight Molecular Diagnostics.com/ for more information. Investor Contact:Doug FarrellLifeSci Advisors LLCdfarrell@lifesciadvisors.com